PerkinElmer introduces no-wash immunoassay to help drive neuroscience disease research forward
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials
Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab
Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel
Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States
Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients
Watch this webinar on demand to learn about the host immune response to COVID-19
Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses
In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery
Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results